Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 1, Pages e30479
Publisher
Public Library of Science (PLoS)
Online
2012-01-19
DOI
10.1371/journal.pone.0030479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
- (2011) Nicolas Veziris et al. PLoS One
- Mycobacterium tuberculosis acg Gene Is Required for Growth and Virulence In Vivo
- (2011) Yanmin Hu et al. PLoS One
- Bactericidal Potencies of New Regimens Are Not Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis
- (2010) K. Andries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
- (2010) José A Caminero et al. LANCET INFECTIOUS DISEASES
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- (2010) Jasvir Dhillon et al. TUBERCULOSIS
- Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
- (2009) Kathy N. Williams et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
- (2009) S. Mendez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started